BACKGROUND AND OBJECTIVE: To quantify the size and location of nonperfusion associated with posterior segment neovascularization (NV) in proliferative diabetic retinopathy (PDR) using ultra-widefield fluorescein angiography. PATIENTS AND METHODS: Cross-sectional study of 18 eyes with PDR. The total image area, areas of nonperfusion, buds of posterior segment neovascularization (either neovascularization of the disc or elsewhere), and the distances from each bud to the nearest area of nonperfusion and to the disc were measured. RESULTS: Nonperfused areas with associated neovascularization were significantly larger than areas without neovascularization (32.0% ± 5.24% of the retinal image vs. 3.3% ± 0.92%; P < .001) and were more likely to be posteriorly located. Nonperfusion encompassing greater than 23% of the total angiographic image had more associated neovascular buds (9.64 ± 2.16 vs. 0.86 ± 0.29; P < .0001), which were closer to the disc (7.53 mm ± 0.27 mm vs. 9.24 mm ± 0.64 mm; P = .014). CONCLUSION: A threshold size of nonperfusion greater than 23% of the retinal image is associated with posterior segment neovascularization and may serve as an indicator of risk for the development of PDR. [Ophthalmic Surg Lasers Imaging Retina. 2019;50:86-92.]. Copyright 2019, SLACK Incorporated.
BACKGROUND AND OBJECTIVE: To quantify the size and location of nonperfusion associated with posterior segment neovascularization (NV) in proliferative diabetic retinopathy (PDR) using ultra-widefield fluorescein angiography. PATIENTS AND METHODS: Cross-sectional study of 18 eyes with PDR. The total image area, areas of nonperfusion, buds of posterior segment neovascularization (either neovascularization of the disc or elsewhere), and the distances from each bud to the nearest area of nonperfusion and to the disc were measured. RESULTS: Nonperfused areas with associated neovascularization were significantly larger than areas without neovascularization (32.0% ± 5.24% of the retinal image vs. 3.3% ± 0.92%; P < .001) and were more likely to be posteriorly located. Nonperfusion encompassing greater than 23% of the total angiographic image had more associated neovascular buds (9.64 ± 2.16 vs. 0.86 ± 0.29; P < .0001), which were closer to the disc (7.53 mm ± 0.27 mm vs. 9.24 mm ± 0.64 mm; P = .014). CONCLUSION: A threshold size of nonperfusion greater than 23% of the retinal image is associated with posterior segment neovascularization and may serve as an indicator of risk for the development of PDR. [Ophthalmic Surg Lasers Imaging Retina. 2019;50:86-92.]. Copyright 2019, SLACK Incorporated.
Authors: Paolo S Silva; Amanda J Dela Cruz; Migil G Ledesma; Jano van Hemert; Ajlan Radwan; Jerry D Cavallerano; Lloyd M Aiello; Jennifer K Sun; Lloyd Paul Aiello Journal: Ophthalmology Date: 2015-09-06 Impact factor: 12.079
Authors: Matthew M Wessel; Grant D Aaker; George Parlitsis; Minhee Cho; Donald J D'Amico; Szilárd Kiss Journal: Retina Date: 2012-04 Impact factor: 4.256
Authors: Paolo S Silva; Jerry D Cavallerano; Jennifer K Sun; Ahmed Z Soliman; Lloyd M Aiello; Lloyd Paul Aiello Journal: Ophthalmology Date: 2013-06-15 Impact factor: 12.079
Authors: Ronald Klein; Michael D Knudtson; Kristine E Lee; Ronald Gangnon; Barbara E K Klein Journal: Ophthalmology Date: 2009-01-22 Impact factor: 12.079
Authors: Joanne W Y Yau; Sophie L Rogers; Ryo Kawasaki; Ecosse L Lamoureux; Jonathan W Kowalski; Toke Bek; Shih-Jen Chen; Jacqueline M Dekker; Astrid Fletcher; Jakob Grauslund; Steven Haffner; Richard F Hamman; M Kamran Ikram; Takamasa Kayama; Barbara E K Klein; Ronald Klein; Sannapaneni Krishnaiah; Korapat Mayurasakorn; Joseph P O'Hare; Trevor J Orchard; Massimo Porta; Mohan Rema; Monique S Roy; Tarun Sharma; Jonathan Shaw; Hugh Taylor; James M Tielsch; Rohit Varma; Jie Jin Wang; Ningli Wang; Sheila West; Liang Xu; Miho Yasuda; Xinzhi Zhang; Paul Mitchell; Tien Y Wong Journal: Diabetes Care Date: 2012-02-01 Impact factor: 19.112
Authors: Eric E Jung; Michelle Lin; Christine Ryu; Stavros N Moysidis; Bruce Burkemper; Rajan Murgai; Amirmohsen Arbabi; Hossein Ameri Journal: J Curr Ophthalmol Date: 2021-03-26
Authors: Ji Won Min; Hyung Duk Kim; Sang Yoon Park; Jun Hyuk Lee; Jae Hyun Park; Anna Lee; Ho Ra; Jiwon Baek Journal: Invest Ophthalmol Vis Sci Date: 2020-12-01 Impact factor: 4.799